Trial Profile
A Phase I, Healthy Volunteer Determination Of 5HT4 Receptor Occupancy Of PF-04995274, Using PET With Ligand [11C]PF-05127401.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jun 2011
Price :
$35
*
At a glance
- Drugs PF 4995274 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- 31 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 15 Sep 2010 Actual initiation date added to 1 Aug 2010 as reported by ClinicalTrials.gov.
- 15 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.